Skip to content

Abnormal Cortical Bone Morphology C4021741

Published: July 22, 2026Updated: August 20, 2026

Changes in the outer dense layer of bone structure. Can affect bone strength and may be associated with various bone disorders.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
M79.9
ICD-11
FA00.0
Body system
musculoskeletal
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Pathological fractures

Bone breaks that occur with minimal trauma due to weakened bone structure from abnormal cortical morphology.

Seek immediate medical care if you suspect a bone fracture, especially with sudden pain, swelling, or inability to bear weight

!

Nerve compression symptoms

Tingling, numbness, or weakness in extremities when abnormal bone growth presses on nerves, particularly in the spine.

Seek immediate care if you experience sudden numbness, weakness, or loss of bladder/bowel control

Bone pain

(musculoskeletal)

Persistent or intermittent pain in affected bones, often worsened by weight-bearing or movement.

Frequency: 70-80% of patients

Bone deformity

(musculoskeletal)

Visible or palpable abnormal shape or contour of bones, often affecting the long bones or skull.

Frequency: 60-70% of patients

Limited joint mobility

(musculoskeletal)

Reduced range of motion in joints near affected bones, making it difficult to perform normal movements.

Frequency: 40-50% of patients

Bone tenderness

(musculoskeletal)

Pain or discomfort when pressure is applied to the affected bone area.

Frequency: 50-60% of patients

Chronic fatigue

(constitutional)

Persistent tiredness and low energy levels that may be related to the metabolic demands of abnormal bone remodeling.

Frequency: 15-20% of patients

Joint swelling

(musculoskeletal)

Swelling around joints adjacent to bones with abnormal cortical morphology, often due to inflammation or stress on joint structures.

Frequency: 10-15% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Nutritional Optimization

Calcium and vitamin D supplementation through diet and supplements to support bone health and potentially improve bone morphology over time.

dietary
3

Weight-bearing Exercise Program

Structured exercise regimen including resistance training and impact activities to stimulate bone remodeling and improve bone density.

physical_therapy

Additional treatment options

Bone Density Surveillance

Regular DEXA scans and clinical evaluation to monitor bone health status and detect any progressive changes in cortical bone morphology.

monitoring

Fall Prevention Strategies

Home safety assessment and modification program to reduce fracture risk, including grab bars, proper lighting, and footwear recommendations.

lifestyle

Corrective Osteotomy

Surgical intervention to realign bone structure in cases where abnormal morphology causes functional impairment or pain.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Cortical Bone Morphology C4021741?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 2014.

guideline2014View source →
2

Seeman E, Delmas PD. Bone quality—the material and structural basis of bone strength. N Engl J Med. 2008;358(21):2254-2266.

review2008View source →
3

World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843. Geneva: WHO; 1994.

guideline1994View source →
4

Reyes C, Garcia-Gil M, Elorza MA, et al. Mendelian randomization: a tool for assessing causal relationship between bone mineral density and fracture. J Bone Miner Res. 2015;30(10):1743-1756.

meta_analysis2015View source →
5

Bouxsein ML. Bone quality: where do we go from here? Osteoporos Int. 2003;14(Suppl 5):S118-S127.

review2003View source →
6

Recker RR, Marin F, Ish-Shalom S, et al. Comparative effects of teriparatide and risedronate on cortical bone measurements by PQCT in postmenopausal women with osteoporosis. J Bone Miner Res. 2010;25(5):1035-1045.

clinical_trial2010View source →
7

Robling AG, Turner CH. Skeletal adaptation to mechanical loading. In: Rosen CJ, Compston JE, Lian JB, editors. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 8th ed. Washington, DC: American Society for Bone and Mineral Research; 2013: pp. 375-382.

textbook2013
8

American Society for Bone and Mineral Research (ASBMR). ASBMR 2014 Position Statement on bone quality. J Bone Miner Res. 2014;29(10):2115-2125.

position_statement2014View source →
9

Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993;94(6):646-650.

consensus1993View source →
10

NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285(6):785-795.

Medication Comparisons

Compare medications used to treat Abnormal Cortical Bone Morphology C4021741. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy